Oct. 4, 2011 — According to a recent article posted today on the Policy and Medicine Web site, the authors of the Physician Payments Sunshine Act — Sens. Charles Grassley (R-Iowa) and Herb Kohl (D-Wis.) — have sent a letter to Centers for Medicare and Medicaid Services Administrator Donald Berwick expressing their “severe disappointment” that proposed regulations to […]
Read moreTag: industry funding
industry fundingPitts on the Politics of Drug Industry Sponsorship
Oct. 3, 2011 – In his recent Drugwonks blog, Peter Pitts, president and co-founder of the Center for Medicine in the Public Interest, suggests that attempts to separate clinicians, medical researchers and drug companies may not be in patients’ best interests. “We must dismantle the battlements and embrace [a] philosophy of ‘symbiosis not schism.’ It’s what’s […]
Read more
Regulatory/FDA
Pitts to Med Policy Pros: Academic Detailing Is Not a Panacea
Pitts to Med Policy Pros: Academic Detailing Is Not a Panacea
From : In a recent blog entry on DrugWonks.com, Peter Pitts, president of the Center for Medicine in the Public Interest, called out the federal government for putting its focus on and committing its dollars to programs that support “academic detailing,” a practice largely conducted by pharmacists to help healthcare professionals better understand medical treatment effectiveness […]
Read moreAMA's CEJA Report Better, but Still Falls Short. Coalition Encourages Discussion and Comments
The Council on Ethical and Judicial Affairs (CEJA) of the American Medical Association (AMA) has recently submitted a report titled “Financial Relationships with Industry in Continuing Medical Education” to a reference committee of the AMA, to be considered for submission to the AMA House of Delegates on June 14th. Although the report is less stifling […]
Read more